Search Results - James Signorovitch

Refine Results
  1. 1
    Individualized Prediction of Changes in 6-Minute Walk Distance for Patients with Duchenne Muscular Dystrophy

    Individualized Prediction of Changes in 6-Minute Walk Distance for Patients with Duchenne Muscular Dystrophy by Nathalie Goemans, M. vanden Hauwe, James Signorovitch, Elyse Swallow, Jinlin Song

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis

    Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis by Michael T. Nurmohamed, Yanjun Bao, James Signorovitch, Alex Trahey, Parvez Mulani, Diana Dan

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: experience at a single, large care center

    Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: experience at a single, large care center by Jessica R. Marden, Jonathan Freimark, Zhiwen Yao, James Signorovitch, Cuixia Tian, Brenda Wong

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    A Review of Two Regulatory Approved Anti-CD19 CAR T-Cell Therapies in Diffuse Large B-Cell Lymphoma: Why Are Indirect Treatment Comparisons Not Feasible?

    A Review of Two Regulatory Approved Anti-CD19 CAR T-Cell Therapies in Diffuse Large B-Cell Lymphoma: Why Are Indirect Treatment Comparisons Not Feasible? by Jie Zhang, Junlong Li, Qiufei Ma, Hongbo Yang, James Signorovitch, Eric Q. Wu

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure

    Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure by Kristina Chen, Fan Mu, Jipan Xie, Sneha S. Kelkar, Olivier Clément, James Signorovitch, Palle Bekker Jeppesen

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Intrinsic Circadian Clock of the Mammalian Retina: Importance for Retinal Processing of Visual Information

    Intrinsic Circadian Clock of the Mammalian Retina: Importance for Retinal Processing of Visual Information by Kai-Florian Storch, Carlos Paz, James Signorovitch, Elio Raviola, Basil S. Pawlyk, Tiansen Li, Charles J. Weitz

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK –Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls

    Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK –Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls by Daniel Shao-Weng Tan, António Araújo, Jie Zhang, James Signorovitch, Zheng‐Yi Zhou, Xiaopeng Cai, Geoffrey Liu

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non‐insulin antidiabetes drugs

    Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non‐insulin antidiabetes drugs by James Signorovitch, Dendy Macaulay, Markus K. Diener, Ying Yan, E.Q. Wu, J.B. Gruenberger, B. M. Frier

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States

    Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States by Sunnie Kim, James Signorovitch, Hongbo Yang, Oscar Patterson‐Lomba, Cheryl Xiang, Brian Ung, Monika Parisi, John L. Marshall

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Categorising trajectories and individual item changes of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy

    Categorising trajectories and individual item changes of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy by Francesco Muntoni, Joana Domingos, Adnan Y. Manzur, Anna Mayhew, Michela Guglieri, Gautam Sajeev, James Signorovitch, Susan J. Ward

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    PIK3CA mutation status, progression and survival in advanced HR + /HER2- breast cancer: a meta-analysis of published clinical trials

    PIK3CA mutation status, progression and survival in advanced HR + /HER2- breast cancer: a meta-analysis of published clinical trials by Mirko Fillbrunn, James Signorovitch, Fabrice André, Iris Wang, Inés Lorenzo, Antonia Ridolfi, Jinhee Park, Akanksha Dua, Hope S. Rugo

    Published 2022
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial

    Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial by Stephen J. Schuster, Richard T. Maziarz, Elisha S. Rusch, Junlong Li, James Signorovitch, Vadim Romanov, Frederick L. Locke, David G. Maloney

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial

    Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial by Richard T. Maziarz, Stephen J. Schuster, Vadim Romanov, Elisha S. Rusch, Junlong Li, James Signorovitch, David G. Maloney, Frederick L. Locke

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Economic burden of acute otitis media, pneumonia, and invasive pneumococcal disease in children in the United States after the introduction of 13-valent pneumococcal conjugate vaccines during 2014–2018

    Economic burden of acute otitis media, pneumonia, and invasive pneumococcal disease in children in the United States after the introduction of 13-valent pneumococcal conjugate vacc... by Tianyan Hu, Yan Song, Nicolae Done, Salini Mohanty, Qing Liu, Eric Sarpong, Esteban Lemus-Wirtz, James Signorovitch, Thomas Weiß

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Comparative safety and efficacy of ozanimod versus fingolimod for relapsing multiple sclerosis

    Comparative safety and efficacy of ozanimod versus fingolimod for relapsing multiple sclerosis by Elyse Swallow, Oscar Patterson‐Lomba, Lei Yin, Rina Mehta, Corey Pelletier, David Kao, James K. Sheffield, Tim Stonehouse, James Signorovitch

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Incidence of acute otitis media in children in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998–2018

    Incidence of acute otitis media in children in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998–2018 by Tianyan Hu, Nicolae Done, Tanaz Petigara, Salini Mohanty, Yan Song, Qing Liu, Esteban Lemus-Wirtz, James Signorovitch, Eric Sarpong, Thomas Weiß

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Linkage Disequilibrium and Inference of Ancestral Recombination in 538 Single-Nucleotide Polymorphism Clusters across the Human Genome

    Linkage Disequilibrium and Inference of Ancestral Recombination in 538 Single-Nucleotide Polymorphism Clusters across the Human Genome by Andrew G. Clark, Rasmus Nielsen, James Signorovitch, Tara C. Matise, Stephen Glanowski, Jeremy Heil, Emily S. Winn-Deen, Arthur L. Holden, Eric Lai

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19

    Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19 by Ankeet S. Bhatt, Karola Jering, Muthiah Vaduganathan, Brian Claggett, Jonathan W. Cunningham, Ning Rosenthal, James Signorovitch, Jens Jakob Thune, Orly Vardeny, Scott D. Solomon

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment

    Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment by Alexa B. Kimball, Gregor B. E. Jemec, Min Yang, Andrew Kageleiry, James Signorovitch, Martin M. Okun, Y. Gu, K. Wang, Parvez Mulani, M Sundaram

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Transfusion-related cost offsets and time burden in patients with myelofibrosis on momelotinib vs. danazol from MOMENTUM

    Transfusion-related cost offsets and time burden in patients with myelofibrosis on momelotinib vs. danazol from MOMENTUM by Lucia Masárová, Srđan Verstovšek, Tom Liu, Sumati Rao, Gautam Sajeev, Mirko Fillbrunn, Ryan Simpson, Weilong Li, Joseph Yuan‐Mou Yang, Yvette Le Lorier, Boris Gorsh, James Signorovitch

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: